Genmab A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US3723032062
20,20 € ↓ -0,20 (-0,98%)
2026-06-04
AKTIENPREIS
SecurityDE:GE91 / Genmab A/S - Depositary Receipt (Common Stock)
InstitutionFirst Horizon Advisors, Inc.
Latest Disclosed Ownership625 shares
Latest Disclosed Value $ 12,912
First Horizon Advisors, Inc. reports 8.49% decrease in ownership of GE91 / Genmab A/S - Depositary Receipt (Common Stock)

On August 6, 2025 - First Horizon Advisors, Inc. filed a 13F-HR form disclosing ownership of 625 shares of Genmab A/S - Depositary Receipt (Common Stock) (DE:GE91) valued at $10,938 USD as of June 30, 2025. The entity filed a previous 13F-HR on April 28, 2025 disclosing 683 shares of Genmab A/S - Depositary Receipt (Common Stock). This represents a change in shares of -8.49% during the quarter. The current value of the position is $12,625 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-06 2025-06-30 13F GENMAB A COMMON STOCK 372303206 625 -58 -8.49 13 -7.69 0.0003
2025-04-28 2025-03-31 13F GENMAB A COMMON STOCK 372303206 683 -159 -18.88 13 -23.53 0.0004
2025-02-03 2024-12-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 842 31 3.82 18 -10.53 0.0005
2024-11-08 2024-09-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 811 -18 -2.17 20 -5.00 0.0005
2024-07-19 2024-06-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 829 0 0.00 21 -16.67 0.0006
2024-04-26 2024-03-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 829 -185 -18.24 25 -25.00 0.0008
2024-02-06 2023-12-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 1,014 -113 -10.03 32 -17.95 0.0011
2023-10-27 2023-09-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 1,127 919 441.83 40 457.14 0.0014
2023-08-03 2023-06-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 208 91 77.78 8 75.00 0.0003
2023-05-15 2023-03-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 117 -103 -46.82 4 -55.56 0.0002
2023-02-10 2022-12-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 220 48 27.91 9 80.00 0.0003
2022-11-09 2022-09-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 172 -313 -64.54 5 -68.75 0.0002
2022-08-02 2022-06-30 13F GENMAB A COMMON STOCK 372303206 485 -1,105 -69.50 16 -72.41 0.0006
2022-05-10 2022-03-31 13F GENMAB A COMMON STOCK 372303206 1,590 164 11.50 58 5.45 0.0025
2022-02-09 2021-12-31 13F GENMAB A COMMON STOCK 372303206 1,426 14 0.99 55 -9.84 0.0017
2021-11-15 2021-09-30 13F/A-1 GENMAB A COMMON STOCK 372303206 1,412 1,376 3,822.22 61 6,000.00 0.0020
2021-11-09 2021-09-30 13F GENMAB A COMMON STOCK 372303206 1,524 1,488 74 0.0011
2021-08-09 2021-06-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 36 36 1 0.0001
2021-02-11 2020-12-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 0 -24 -100.00 0 -100.00 0.0000
2020-11-12 2020-09-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 24 -572 -95.97 0 -100.00
2020-07-31 2020-06-30 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS COMMON STOCK 372303206 596 0 0.00 20 66.67 0.0016
2020-05-05 2020-03-31 13F GENMAB AS SPON ADS EACH REP 0.1 ORD SHS Common Stock 372303206 596 596 12 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.